Latest news
Loading news…
Pikavation Therapeutics
ActiveOperating status — whether the company still runs independently. “Closed” usually means it was acquired, merged, or shut down.🔥 HighHeat score — how much recent activity & attention the company has (web traffic, news, hiring).📈 Low growthGrowth score — momentum trend across web traffic, headcount and other growth signals. For Profit
Pikavation Therapeutics is a wholly owned subsidiary of Synnovation Therapeutics.
Pikavation Therapeutics on Acquirezy — acquisitions, funding rounds, investments, investors, key people & contacts.
Pikavation Therapeutics was acquired by Novartis in 2026 for $2B.
Last Funding
Acquisitions
0
Monthly Visits
Contacts
0
About Pikavation Therapeutics
Funding & Financials
- Total funding
- Funding rounds
- Last funding
- Last funding type
- Last funding date
- Funding status
- Total equity funding
- Revenue range
IPO & Stock
- IPO status
- Private
Web Traffic
- Monthly visits
- Global traffic rank
- 6-mo avg visits
- Visit duration (s)
- Pages / visit
- Bounce rate
- Rank change (mo)
Technology & IP
- IT spend
- $8.82M
Company Info
- Operating status
- Active
- Company type
- For Profit
- Org types
- company
- News articles
- 13
- Exit date
- Mar 20, 2026
Signals & Scores
- Heat score
- High
- Growth score
- Low
- Trend (7d)
- 0
- Trend (30d)
- 3
- Trend (90d)
- -1
Explore 200,000+ acquisitions — free
Filter the full database across sectors, companies, dates, and deal sizes. No signup, no paywall.
Bulk Dataset Export
Need the data in bulk? Buy the entire dataset.
5.4M company profiles200K+ acquisitions700K+ funding rounds327K investors2M+ people61M contacts45K schools
Delivered as CSV, JSON or Parquet — at startup-friendly pricing.
Recent News related to Pikavation Therapeutics
Loading news…
FAQs about Pikavation Therapeutics
People who checked this page also checked these
Browse the full Acquirezy directory.